Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 4 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
31 53.2 months Ovarian cancer 5 Chemotherapy
Istituto Nazionale Tumori Italy 9/2011
Treatment Details: Patients: This phase II study involved patients with stage IC to IV ovarian cancer not previously treated with chemotherapy who were separated into two different treatment groups. Groups A
 
32 52.9 months Metastatic colorectal 2 Biologic therapy
Immunotherapy
Ospedale Civile di Avezzano Italy 9/2006
Treatment Details: Patients: This phase II study compared two groups of patients. The group receiving the study treatment consisted of 40 people, 26 men and 14 women. The other group, historical controls, co
 
33 52.9 months colorectal (metastatic) 2 Biologic therapy
Immunotherapy
Ospedale Civile di Avezzano Italy 9/2006
Treatment Details: Patients: This phase II study compared two groups of patients. The group receiving the study treatment consisted of 40 people, 26 men and 14 women. The other group, historical controls, co
 
34 51.8 months Bladder cancer 5 Chemotherapy
Central Institute of Mental Health Manheim/University of Heidelberg Germany 8/2005
Treatment Details: Patients: This phase III study involved patients with locally advanced bladder cancer who had previously undergone surgery to treat their cancer. Patients were divided into 2 separate trea
 
35 51.6 months Residual stage III ovarian cancer 5 Chemotherapy
Albert Einstein College of Medicine United States 8/2009
Treatment Details: Patients: This phase 2 study involved 63 women with stage 3 ovarian cancer. The median age was 59, ranging from 34 to 80 years old. Treatment: Patients were treated with chemotherapy dr
 
36 51.0 months NHL 5 Biologic therapy
Chemotherapy
Hormone
Mansoura University Egypt 11/2014
Treatment Details: Patients: This study involved HCV-positive diffuse large B-cell lymphoma patients who were divided into two separate treatment groups. Group A consisted of 200 patients with an average age
 
37 50.0 months Indolent NHL 4 Biologic therapy
Radiation
University of Western Australia, Fremantle Hospital Australia 9/2006
Treatment Details: Patients: This phase II study involved 91 indolent non-Hodgkin’s lymphoma patients with a median patient age of 62 years; 60% were male. Treatment: Patients were treated with radiation
 
38 49.4 months Resectable metastatic colorectal carcinoma to the liver 5 Surgery
Queens Hospital Center United States 3/2002
Treatment Details: Patients: This trial involved patients with one to three potentially resectable metastases of colorectal carcinoma to the liver. There were a total of 75 “assessable” patients in this trial
 
39 49.4 months Resectable metastatic colorectal carcinoma to the liver 5 Surgery
Queens Hospital Center United States 3/2002
Treatment Details: Patients: This trial involved patients with one to three potentially resectable metastases of colorectal carcinoma to the liver. There were a total of 75 “assessable” patients in this trial
 
40 48.7 months Mucosal melanoma 4 Chemotherapy
Peking University Cancer Hospital & Institute China 8/2013
Treatment Details: Patients: This phase 2 study involved mucosal melanoma patients who were divided into two separate treatment groups. Group A consisted of 63 patients with a median age of 55 years; 39.7% w
 
Page 4 of 187  | Previous Page  | Next Page